News articles

News article list

• Thousands of appointments released for the NHS without compromising safety

  Delivering fewer radiotherapy sessions over a shorter period of time, first introduced during COVID, benefits patients and the system long-term

• First treatment to target heart condition set to benefit

  NICE has approved mavacamten, the first treatment that specifically targets a heart condition called obstructive hypertrophic cardiomyopathy (HCM). It means around 7,000 people will now be able to access the treatment on the NHS.

• 145,000 people in England to have further treatment choice for preventing migraine attacks

  NICE has for the first time recommended an oral treatment for preventing migraines.

• NICE welcomes life sciences review recommendations

  NICE’s priority is to get the best care to patients fast while ensuring value for the taxpayer.

• Testing could help prevent further strokes in people with gene variant

  People who have had an ischaemic stroke or transient ischaemic attack should have a genetic test to find out whether they can be treated with a drug which reduces the risk of further strokes

• NICE draft guidance recommends new treatment for chronic heart failure

  Up to 150,000 people in England with a type of chronic heart failure are set to benefit from a new treatment following its approval by NICE.